Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
26,094
Total Claims
$2.8M
Drug Cost
1,128
Beneficiaries
$2,518
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-89%
Opioid rate vs peers
0.2% vs 2.2% avg
+78%
Cost per patient vs peers
$2,518 vs $1,411 avg
+55%
Brand preference vs peers
16.5% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.2%
Opioid Rate
63
Opioid Claims
$553
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 4,267 claims · $2.3M
Generic: 21,649 claims · $495K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 236 | $223K |
| Rivaroxaban | 214 | $196K |
| Dulaglutide | 156 | $195K |
| Dapaglifloz Propaned/Metformin | 144 | $154K |
| Apixaban | 131 | $140K |
| Empagliflozin | 108 | $121K |
| Levothyroxine Sodium | 1,166 | $98K |
| Insulin Glargine,hum.Rec.Anlog | 212 | $82K |
| Empaglifloz/Linaglip/Metformin | 68 | $64K |
| Empagliflozin/Linagliptin | 55 | $56K |
| Sitagliptin Phos/Metformin Hcl | 45 | $50K |
| Empagliflozin/Metformin Hcl | 53 | $40K |
| Insulin Lispro | 90 | $37K |
| Sitagliptin Phosphate | 44 | $35K |
| Ticagrelor | 36 | $33K |
Prescribing Profile
Patient Profile
73
Avg Age
62%
Female
2.05
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data